JMJulie Teresa Marchesan

Julie Teresa Marchesan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julie Teresa Marchesan has a total of 208 co-authors. Here are the top co-authors by number of shared publications:

  • Yizu Jiao

    Division of Comprehensive Oral Health (Periodontology), Adams School of Dentistry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

    5 shared publications
  • Karen V. Swanson

    Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    4 shared publications
  • Kevin Moss

    Department of Biostatistics and Health Data Science, School of Medicine, Indiana University

    4 shared publications
  • Kimon Divaris

    Department of Pediatric Dentistry and Dental Public Health, Adams School of Dentistry, University of North Carolina at Chapel Hill, NC, USA

    4 shared publications
  • Tomaz Alves

    Division of Comprehensive Care, Department of Periodontology, University of North Carolina at Chapel Hill

    4 shared publications
  • James D. Beck

    Department of Periodontology, Endodontics, and Dental Hygiene, Adams School of Dentistry (J.B.), University of North Carolina, Chapel Hill

    3 shared publications

Latest Publications

  • Open Access

    Toward Sex-Specific Host Modulation Therapy for Periodontitis

    by D.N. Araujo Silva, V.L. Ribeiro, K.V. Swanson, F. Pirih, J.T. Marchesan

    Periodontitis, a leading cause of tooth loss worldwide, arises from a dysregulated host immune response, and males consistently show higher prevalence and more severe disease than females. This disparity historically has been attributed to behavioral/environmental factors, but growing evidence indicates that biological sex, acting through hormonal signaling and sex chromosome–linked genetic mechanisms, independently shapes periodontal immune responses and subsequent bone resorption. In this review, we examine preclinical and clinical evidence on the impact of biological sex on host modulation therapies to prevent periodontitis. The IL-1β/inflammasome pathway and osteoclast differentiation via receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) signaling both show clear sex-dependent regulation in experimental periodontitis, illustrating the biological complexity that single-target therapies must address in this heterogeneous condition. In a mouse model, inflammasome-mediated IL-1β signaling drives alveolar bone loss selectively in males, while females progress to comparable bone loss through IL-1β–independent mechanisms. IL-17 plays a dual role, driving inflammatory bone resorption while also supporting antimicrobial defense, and evidence points to this balance being sex dependent, with more severe effects observed in females when IL-17 signaling is disrupted. IL-6 is an established driver of periodontal bone loss, and although sex-specific data within periodontitis remain limited, sex-dependent anti–IL-6 receptor treatment responses have been observed in other inflammatory diseases that warrant further investigation. Complement-mediated immunity shows biological sex differences in humans and animal models, though whether these discrepancies directly influence periodontal disease progression needs to be determined. Resolvins and cyclooxygenase inhibitors also show sex-dependent effects outside the periodontal field. Collectively, this evidence positions biological sex as a tractable, currently underappreciated variable to improve host modulation strategies. Incorporating sex as a biological variable into preclinical and clinical periodontal research and ensuring sex-disaggregated data reporting offer a clear opportunity to develop precise, sex-informed nonsurgical therapeutics that better serve both male and female patients.

  • Dental Flossing May Lower the Risk for Incident Ischemic Stroke, Cardioembolic Stroke Subtype, and Atrial Fibrillation

    by Souvik Sen, Julie T. Marchesan, Kevin Moss, Stefanie M. Wood, Alana E. Barton, Alvaro Alonso, Elsayed Z. Soliman, Jared W. Magnani, Michelle C. Johansen, Kamakshi Lakshminarayan, et al.

    BACKGROUND: Prior studies have demonstrated an association between oral infection and both incident stroke and atrial fibrillation (AF), a major cause of cardioembolic stroke. However, the impact of preventive oral behaviors such as dental flossing on incident stroke and AF remains unclear. We evaluated the relationship between flossing, incident stroke subtypes, and AF from the ARIC study (Atherosclerosis Risk in Communities). METHODS: We conducted a prospective cohort study using data from the ARIC study. Flossing was assessed via a structured questionnaire at visit 4 (1996–1998). Participants were censored at the first stroke, death, or loss-to-follow-up through December 31, 2021. Incident ischemic stroke and subtypes were evaluated using Cox proportional hazards models, adjusting for cardiovascular risk factors, education, regular brushing, dental care utilization, periodontal disease, and dental caries. RESULTS: Among 6200 dentate participants without prior stroke, 65% (n=4049) reported regular flossing. Flossers had significantly lower prevalence of vascular risk factors, periodontal disease, and dental caries at baseline. Flossers had lower IL (interleukin)-6 levels in crude analysis, but this difference was explained by confounding from age, body mass index, and smoking. CRP (C-reactive protein) levels did not differ between groups. During a median 23.7 years follow-up, 434 ischemic strokes occurred, including 146 thrombotic, 102 cardioembolic, 95 lacunar, and 91 other ischemic subtypes. Nonflossers had higher rates of both ischemic stroke (8.7% versus 6.1%) and nonstroke mortality (40.8% versus 34.5%). Flossing was associated with lower risk of ischemic stroke (adjusted hazard ratio, 0.77 [95% CI, 0.64–0.96]), cardioembolic stroke (adjusted hazard ratio, 0.60 [95% CI, 0.38–0.94]), and AF (adjusted hazard ratio, 0.88 [95% CI, 0.77–0.99]) with dose-response relationship ( P trend=0.001) 6.6% of the effect mediated by lower AF incidence. Results remained robust in competing risk analysis (adjusted hazard ratio, 0.79 [95% CI, 0.63–0.98]) with an E value of 1.87. CONCLUSIONS: Regular flossing was associated with a lower risk of ischemic stroke, primarily driven by reductions in cardioembolic stroke and AF, independent of other oral health behaviors. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005131.


  • Optimization of the Ligature-induced Periodontitis Mouse Model for Preclinical Research

    by Michael D. Dill, Mustafa Girnary, Tomaz Alves, Kimon Divaris, Glenn Walters, Pollyana Coelho Pessoa Santos, Hannah Preisser, Kevin Moss, Julie T. Marchesan

    The experimental model of ligature-induced periodontitis in mice has played a fundamental role in understanding periodontal disease pathogenesis; yet, it has not been fully leveraged for translational and therapeutic applications. Similar to human disease, ligature-induced periodontitis in mice develops via a series of distinct microbial, inflammatory, and osteo-immunological events. The ligature-induced alveolar bone destruction progresses in a reasonably short period and is easily quantifiable, making it a cost-effective disease model for preclinical studies. To overcome the technical challenge of the classic ligature model, the establishment of the simplified ligature-induced periodontitis mouse model was curated. Rather than inducing disease in the entire circumference of two adjacent teeth, the simplified disease model is centered on inflammatory bone destruction only in the interproximal region of two posterior teeth, which is also the region that common periodontal disease initiates in humans. Because it employs three dimensional (3D)-printed tools for ligature placement, the approach is fast and effective leading to a procedural time of 5-10 min per mouse. While osteoclastogenic signaling is detected after 3 days of ligature placement, bone destruction consistently develops at 9 days post ligation. Here, the simplified ligature model protocol is elaborated by highlighting important elements specific to study design (i.e., power calculation, procedure standardization, calibration), development of the 3D printed tools (i.e., the "mouse dental bed" and "ligature holder"), and alveolar bone quantification using μCT analysis. Gingival gene expression of Rank, Rankl, and Opg, a master regulatory triad of osteoclastogenesis, is used as indirect evidence of therapeutic effectiveness. The methods presented in this paper will guide investigators' implementation of the simplified ligature-induced periodontitis model to test innovative periodontal therapeutics in the preclinical setting.

  • Open Access

    Inflammasome targeting for periodontitis prevention is sex dependent

    by Tomaz Alves, Karen V. Swanson, Mustafa S. Girnary, Marcelo Freire, Kevin Moss, Kimon Divaris, James Beck, Pollyana Coelho Pessoa Santos, W. June Brickey, John A. Wrobel, et al.

    Inflammasome initiates inflammation via the maturation of interleukin-1 beta (IL-1β). Periodontitis is a prevalent, male-biased disease characterized by inflammation-driven bone loss, yet the mechanism(s) of this sex bias is unknown. This study explored whether enhanced inflammasome represents a causal mechanism for this bias. Analyses of three separate human studies (>6,200 samples) show that males have significantly higher IL-1β in the gingival crevicular fluid than females during health and periodontitis. This pattern is experimentally reproduced with different versions of the ligature-induced periodontitis mouse model where males show greater IL-1β secretion than females. The inflammasome drives bone resorption in males but not females as revealed by analyses of inflammasome gene-deletion mice. Pharmacologic treatment with a caspase-1/4 inhibitor reduces inflammatory cell infiltration, dampens osteoclastogenesis signaling (via the receptor activator of nuclear factor-kappa B pathway), and prevents bone resorption in males but not females during experimental periodontitis. While ovariectomized females show no change in their nonresponsiveness to caspase-1/4 inhibition, orchiectomized males no longer respond to the inhibition, suggesting the importance of an intact male reproductive system in the mediation of this inhibition. Thus, our study identifies inflammasome activation as causal for male-biased experimental periodontitis and supports sex-stratified studies to foster future advancement of inflammasome therapeutics in periodontics.


  • Open Access

    Peri‐implant inflammation increases the risk of osteonecrosis in mice treated with bisphosphonate

    by Ana Bujila, Davi N. A. Silva, Sepehr Monajemzadeh, Taciane M. da Silveira, Naseim Elzakra, Maísa Casarin, Kimberly Flores, Clara Magyar, Julie Marchesan, Reuben Kim, et al.

    Background: Bisphosphonates (BPs) are effective in managing bone diseases due to their anti‐resorptive properties but are linked to medication‐related osteonecrosis of the jaw (MRONJ), particularly concerning dental implants. This study explored the combined impact of ligature‐induced peri‐implant inflammation and zoledronic acid (ZA), a BP, using a murine model.Methods: Twenty‐four mice underwent bilateral maxillary molar extractions and implant placements, with ZA or vehicle treatment and ligature placement on the left side. Two groups were defined: group 1 (vehicle‐treated) with control (Veh‐C) and ligature (Veh‐L) implants, and group 2 (ZA‐treated) with control (ZA‐C) and ligature (ZA‐L) implants. Clinical, micro‐CT, histological, and immunohistochemical analyses were performed. We hypothesized that peri‐implant inflammation elevates MRONJ risk with BP treatment.Results: Ligature groups showed increased soft tissue edema compared to controls, without differences between vehicle and ZA treatments. The Veh‐L group exhibited significantly greater bone loss than other groups. Histology showed higher inflammatory infiltrate in ligature groups. Osteocyte empty lacunae and osteonecrosis were significantly greater in ZA‐L. Picrosirius red staining revealed disorganized collagen fibers and separation in ZA‐L. Immunohistochemistry showed increased neutrophils (NIMP‐R14+) and monocytes/macrophages (CD11b+) in the ligature groups, with no significant differences between Veh‐C and ZA‐C.Conclusion: Ligature treatment enhances peri‐implant inflammation, with ZA heightening the risk of MRONJ. These findings highlight the critical importance of early detection and management of peri‐implant inflammation in patients undergoing BP therapy, particularly those at high risk of MRONJ. Clinicians should emphasize preventive measures, such as regular monitoring of peri‐implant health and reducing local inflammatory triggers, to mitigate the adverse effects of BPs on peri‐implant bone health.Plain Language Summary: Dental implants are a reliable solution to replace missing teeth. However, like natural teeth, implants can develop inflammation around them—peri‐implantitis. Our study found that, when this inflammation occurs in patients taking BPs (a medication commonly used to treat osteoporosis and other bone diseases), the risk of developing a serious jaw condition called osteonecrosis (ONJ) increases significantly. ONJ prevents the jawbone from healing properly, leading to pain, infection, and even exposed bone. These findings highlight the importance of preventing and managing inflammation around dental implants to reduce the risk of complications, especially in patients taking BPs. Our research suggests regular dental check‐ups and proper oral hygiene can help maintain implant health and prevent severe bone‐related conditions. Patients and healthcare providers can take proactive steps to improve long‐term oral health outcomes by understanding these risks.


  • Open Access

    TRAF3IP2–IL-17 Axis Strengthens the Gingival Defense against Pathogens

    by J. Zhang, L. Sun, M.H.H. Withanage, S.M. Ganesan, M.A. Williamson, J.T. Marchesan, Y. Jiao, F.R. Teles, N. Yu, Y. Liu, et al.

    Recent genome-wide association studies have suggested novel risk loci associated with periodontitis, which is initiated by dysbiosis in subgingival plaque and leads to destruction of teeth-supporting structures. One such genetic locus was the tumor necrosis factor receptor–associated factor 3 interacting protein 2 ( TRAF3IP2), a gene encoding the gate-keeping interleukin (IL)–17 receptor adaptor. In this study, we first determined that carriers of the lead exonic variant rs13190932 within the TRAF3IP2 locus combined with a high plaque microbial burden was associated with more severe periodontitis than noncarriers. We then demonstrated that TRAF3IP2 is essential in the IL-17–mediated CCL2 and IL-8 chemokine production in primary gingival epithelial cells. Further analysis suggested that rs13190932 may serve a surrogate variant for a genuine loss-of-function variant rs33980500 within the same gene. Traf3ip2 null mice ( Traf3ip2–/–) were more susceptible than wild-type (WT) mice to the Porphyromonas gingivalis–induced periodontal alveolar bone loss. Such bone loss was associated with a delayed P. gingivalis clearance and an attenuated neutrophil recruitment in the gingiva of Traf3ip2–/– mice. Transcriptomic data showed decreased expression of antimicrobial genes, including Lcn2, S100a8, and Defb1, in the Traf3ip2–/– mouse gingiva in comparison to WT mice prior to or upon P. gingivalis oral challenge. Further 16S ribosomal RNA sequencing analysis identified a distinct microbial community in the Traf3ip2–/– mouse oral plaque, which was featured by a reduced microbial diversity and an overabundance of Streptococcus genus bacteria. More P. gingivalis was observed in the Traf3ip2–/– mouse gingiva than WT control animals in a ligature-promoted P. gingivalis invasion model. In agreement, neutrophil depletion resulted in more local gingival tissue invasion by P. gingivalis. Thus, we identified a homeostatic IL-17-TRAF3IP2-neutrophil axis underpinning host defense against a keystone periodontal pathogen.


  • Oral biofilm dysbiosis during experimental periodontitis

    by Apoena Aguiar Ribeiro, Yizu Jiao, Mustafa Girnary, Tomaz Alves, Liang Chen, Anna Farrell, Di Wu, Flavia Teles, Naohiro Inohara, Karen V. Swanson, et al.

    Objectives: We have previously characterized the main osteoimmunological events that occur during ligature periodontitis. This study aims to determine the polymicrobial community shifts that occur during disease development.Methods: Periodontitis was induced in C57BL/6 mice using the ligature‐induced periodontitis model. Healthy oral mucosa swabs and ligatures were collected every 3 days from 0 to 18 days post‐ligature placement. Biofilm samples were evaluated by 16SrRNA gene sequencing (Illumina MiSeq) and QIIME. Time‐course changes were determined by relative abundance, diversity, and rank analyses (PERMANOVA, Bonferroni‐adjusted).Results: Microbial differences between health and periodontal inflammation were observed at all phylogenic levels. An evident microbial community shift occurred in 25 genera during the advancement of “gingivitis” (3–6 days) to periodontitis (9–18 days). From day 0 to 18, dramatic changes were identified in Streptococcus levels, with an overall decrease (54.04%–0.02%) as well an overall increase of Enterococcus and Lactobacillus (23.7%–73.1% and 10.1%–70.2%, respectively). Alpha‐diversity decreased to its lowest at 3 days, followed by an increase in diversity as disease advancement. Beta‐diversity increased after ligature placement, indicating that bone loss develops in response to a greater microbial variability (p = 0.001). Levels of facultative and strict anaerobic bacteria augmented over the course of disease progression, with a total of eight species significantly different during the 18‐day period.Conclusion: The data supports that murine gingival inflammation and alveolar bone loss develop in response to microbiome shifts. Bacterial diversity increased during progression to bone loss. These findings further support the utilization of the periodontitis ligature model for microbial shift analysis under different experimental conditions.


  • Interferon‐gamma inducible protein 16 and type I interferon receptors expression in experimental apical periodontitis induced in wild‐type mice

    by Carolina Maschietto Pucinelli, Ricardo B. Lima, Lana K. Y. Almeida, Marilia P. Lucisano, Amily Z. Córdoba, Julie T. Marchesan, Lea A. B. da Silva, Raquel A. B. da Silva

    Aim: The aim of this study was to evaluate the IFI16 and IFN‐α/β receptors expression during the genesis and development of experimental apical periodontitis (AP) in mice teeth.Methodology: Apical periodontitis was induced in the lower first molars of 40 C57BL/6 mice. They were divided according to the experimental periods 2, 7, 14, 21 and 42 days (n = 8 per group). Five animals were used as a control group (without AP). Specimens were submitted to histological processing for description of the inflammatory process, immunostaining for the presence/absence and localization of IFI16 and IFN‐α/β receptors (qualitative and semi‐quantitative analysis) and tartrate‐resistant acid phosphatase (TRAP) histoenzimology.Results: The results showed a gradual development of AP over the experimental times. The expression of IFI16 was noticeably more exacerbated in the experimental early period (day 2) whilst the lowest expression was observed in the control group (p = .02). For IFN‐α/β receptors, a higher intensity staining was observed 42 days after AP induction, that was statistically different from the control group (p = .02). In addition, the number of TRAP‐positive cells was higher on the later periods (days 21 and 42; p < .001).Conclusion: IFI16 protein expression was highest during the early periods after AP induction in mice teeth, whilst IFN‐α/β receptor expression was highest after AP became established.


  • Interferon activated gene 204 protects against bone loss in experimental periodontitis

    by Karen V. Swanson, Mustafa Girnary, Tomaz Alves, Jenny Py Ting, Kimon Divaris, Jim Beck, Carolina Maschietto Pucinelli, Raquel Assed Bezerra da Silva, Dilek Uyan, Justin E. Wilson, et al.

    Background: Periodontal destruction can be the result of different known and yet‐to‐be‐discovered biological pathways. Recent human genetic association studies have implicated interferon‐gamma inducible protein 16 (IFI16) and absent in melanoma 2 (AIM2) with high periodontal interleukin (IL)‐1β levels and more destructive disease, but mechanistic evidence is lacking. Here, we sought to experimentally validate these observational associations and better understand IFI16 and AIM2's roles in periodontitis.Methods: Periodontitis was induced in Ifi204–/– (IFI16 murine homolog) and Aim2–/– mice using the ligature model. Chimeric mice were created to identify the main source cells of Ifi204 in the periodontium. IFI16‐silenced human endothelial cells were treated with periodontal pathogens in vitro. Periodontal tissues from Ifi204–/– mice were evaluated for alveolar bone (micro‐CT), cell inflammatory infiltration (MPO+ staining), Il1b (qRT‐PCR), and osteoclast numbers (cathepsin K+ staining).Results: Ifi204‐deficient mice> exhibited >20% higher alveolar bone loss than wild‐type (WT) (P < 0.05), while no significant difference was found in Aim2–/– mice. Ifi204's effect on bone loss was primarily mediated by a nonbone marrow source and was independent of Aim2. Ifi204‐deficient mice had greater neutrophil/macrophage trafficking into gingival tissues regardless of periodontitis development compared to WT. In human endothelial cells, IFI16 decreased the chemokine response to periodontal pathogens. In murine periodontitis, Ifi204 depletion elevated gingival Il1b and increased osteoclast numbers at diseased sites (P < 0.05).Conclusions: These findings support IFI16's role as a novel regulator of inflammatory cell trafficking to the periodontium that protects against bone loss and offers potential targets for the development of new periodontal disease biomarkers and therapeutics.


  • Open Access

    The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications

    by Julie Teresa Marchesan, Blake M. Warner, Kevin Matthew Byrd

    Severe acute respiratorysyndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19, has led to more than 3.25 million recorded deaths worldwide as of May 2021. COVID‐19 is known to be clinically heterogeneous, and whether the reported oral signs and symptoms in COVID‐19 are related to the direct infection of oral tissues has remained unknown. Here, we review and summarize the evidence for the primary infection of the glands, oral mucosae, and saliva by SARS‐CoV‐2. Not only were the entry factors for SARS‐CoV‐2 found in all oral tissues, but these were also sites of SARS‐CoV‐2 infection and replication. Furthermore, saliva from asymptomatic individuals contained free virus and SARS‐CoV‐2‐infected oral epithelial cells, both of which were found to transmit the virus. Collectively, these studies support an active role of the oral cavity in the spread and transmission of SARS‐CoV‐2 infection. In addition to maintaining the appropriate use of personal protective equipment and regimens to limit microbial spread via aerosol or droplet generation, the dental community will also be involved in co‐managing COVID‐19 “long haulers”—now termed Post‐Acute COVID‐19 Syndrome. Consequently, we propose that, as SARS‐CoV‐2 continues to spread and as new clinical challenges related to COVID‐19 are documented, oral symptoms should be included in diagnostic and prognostic classifications as well as plans for multidisciplinary care.